ArticleCase reports in gastroenterology
Pseudocirrhosis: A Case Series and Literature Review.
Article in Case reports in gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.
- Pseudocirrhosis and portal hypertension in patients with metastatic cancers: a systematic review and meta-analysis.Scientific reports · 2022Pooled it
- Imaging findings of post-chemotherapy non-metastatic hepatic parenchymal changes.Journal of clinical imaging science · 2025Article
- Article
- Pseudocirrhosis: A Case Series with Clinical and Radiographic Correlation and Review of the Literature.Digestive diseases and sciences · 2024Review
- Clinical Outcomes of Metastatic Breast Cancer in Patients Having Imaging Liver Pseudocirrhosis with or without Evident Varices.The oncologist · 2022Article
- Liver metastases - An unusual cause of portal hypertension: A case report.Annals of medicine and surgery (2012) · 2022Article
- Pseudocirrhosis Due to Desmoplastic Response to Chemotherapy in Breast Cancer Liver Metastases.Cureus · 2022Article
- Transjugular intrahepatic portosystemic shunt for the management of symptomatic malignant pseudocirrhosis.Journal of gastrointestinal oncology · 2022Article
- Pseudocirrhosis after chemotherapy for gastric cancer with diffuse liver metastases: A case report.Molecular and clinical oncology · 2022Article
- Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis.World journal of gastroenterology · 2021Article
- Pseudocirrhosis due to liver metastasis from lung adenocarcinoma.Thoracic cancer · 2021Article
- Pseudocirrhosis caused by lung adenocarcinoma with diffuse liver metastasis: An autopsy case report.Thoracic cancer · 2021Article
- A fatal case of metastatic gastric adenocarcinoma mimicking cirrhosis.Autopsy & case reports · 2021Article
- Prospective observational study of bevacizumab combined with paclitaxel as first- or second-line chemotherapy for locally advanced or metastatic breast cancer: the JBCRG-C05 (B-SHARE) study.Breast cancer (Tokyo, Japan) · 2021Observational
- Pseudocirrhosis in Breast Cancer - Experience From an Academic Cancer Center.Frontiers in oncology · 2021Article
- Other types of diffuse liver disease: is there a way to do it?Abdominal radiology (New York) · 2020Review
- Pseudocirrhosis in Chronic Budd Chiari Syndrome With Janus Tyrosine Kinase 2 (JAK2) Mutation.Cureus · 2020Article
- Article
- Recurrent metastatic breast cancer presenting with portal hypertension and pseudocirrhosis.BMJ case reports · 2019Article
- Spider Telangiectases and Palmar Erythema as Harbingers of Structural Liver Changes in Three Breast Cancer Patients on Ado-trastuzumab Emtansine.The Journal of clinical and aesthetic dermatology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudocirrhosis describes morphological changes of the liver that closely mimic cirrhosis, without the typical histopathological changes seen in cirrhosis. It most commonly occurs in patients with metastatic breast cancer, although it has been reported in other malignancies as well. Like in cirrhosis, portal hypertension is often seen in patients with pseudocirrhosis. Pseudocirrhosis is a rare but important complication of metastatic cancer. In this case series and literature review, we describe 6 patients with hormone-receptor-positive metastatic breast cancer. We report the significant morbidity associated with pseudocirrhosis in the course of treatment in patients with metastatic breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.